Online insomnia treatment
in California.

Insomnia and its psychiatric roots

Most insomnia presenting to a psychiatric practice is not primary — it's a symptom of something else. Anxiety keeps the brain in vigilance mode past the point where sleep is possible. Depression disrupts sleep architecture, causing frequent awakenings or early morning waking. ADHD leads to delayed sleep phase — difficulty winding down, racing thoughts at night, and late-to-bed patterns. PTSD causes hyperarousal and nightmares that fracture sleep. Bipolar disorder, substance use, and even unmanaged chronic pain all affect sleep significantly.

Treating the underlying condition often resolves the insomnia. Treating insomnia without identifying the underlying cause results in dependence on sleep aids that don't address the root.

Primary insomnia

When insomnia persists even after treating co-occurring conditions, or when no clear psychiatric cause is identified, insomnia is evaluated as a primary condition. Primary insomnia is a diagnosis of exclusion — it requires ruling out other explanations first. Medical causes (sleep apnea, restless legs, thyroid, chronic pain) and medications are also considered.

CBT-I (Cognitive Behavioral Therapy for Insomnia) is the gold standard treatment for primary insomnia and produces more durable results than medication alone. It involves sleep restriction, stimulus control, and cognitive restructuring. Finding a CBT-I trained therapist can be difficult, but the approach is worth seeking out.

Medication for insomnia

The goal with sleep medication is to address the specific mechanism at play — not to provide a general sedative indefinitely. Non-habit-forming options are preferred whenever possible.

Non-habit-forming options

• Hydroxyzine: an antihistamine with sedating properties, no dependency risk, commonly used for anxiety-driven sleep onset difficulty
• Mirtazapine (low dose): an antidepressant that at low doses (7.5–15 mg) has pronounced sedating and appetite-stimulating effects; often chosen when depression, anxiety, or low appetite co-occur
• Trazodone: an antidepressant widely used off-label for insomnia; not habit-forming and generally well-tolerated
• Low-dose quetiapine: an atypical antipsychotic used off-label for insomnia at doses well below its antipsychotic range; useful when anxiety or mood instability also contribute

Medications approached with caution

Benzodiazepines (lorazepam, temazepam) and Z-drugs (zolpidem, eszopiclone) are effective short-term but carry real risks of tolerance, dependence, and withdrawal with continued use. They suppress normal sleep architecture with chronic use. These are not prescribed as long-term solutions.

Melatonin and supplements

Melatonin is available over-the-counter and can help with sleep timing — particularly for delayed sleep phase. It is not a sedative. The evidence supports its use for circadian rhythm issues more than for typical insomnia.

ADHD and sleep timing

ADHD is commonly associated with delayed sleep phase — difficulty initiating sleep at a conventional time, often combined with difficulty waking in the morning. Stimulant dosing timing matters: taking stimulants too late in the day can significantly worsen sleep onset. This is one reason ADHD management and insomnia cannot always be addressed separately.

What follow-up care looks like for insomnia

Insomnia treatment doesn't always require long-term psychiatric follow-up. When insomnia is secondary to another condition — anxiety, depression, ADHD — treating that condition is the primary work, and sleep often improves in parallel. Follow-up appointments track both.

When sleep medication is prescribed alongside treatment for a co-occurring condition, the goal is to use it for the shortest period necessary. As the underlying condition responds to treatment, the need for a dedicated sleep medication often decreases. Discontinuing sleep medications gradually, with monitoring, is part of the plan from the beginning — not an afterthought.

For primary insomnia, the follow-up rhythm is similar to other conditions: monthly while treatment is being established, extending to every two to three months once stable. If CBT-I is incorporated, coordination with the therapist can happen through the patient — you don't need a formal referral arrangement for that to work.

Sleep is not separate from psychiatric health. It's one of the clearest indicators of how well treatment is working. The provider pays attention to it at every visit.

Insurance and cost

Accepted plans: Aetna, Anthem Blue Cross California, Carelon Behavioral Health, Cigna, Optum, Oxford, Quest Behavioral Health, and UnitedHealthcare. See insurance details or call (323) 970-2625.

What to expect at your insomnia evaluation

The evaluation covers your full sleep picture: how long you've had sleep difficulties, whether the problem is getting to sleep, staying asleep, or waking too early, how the insomnia affects your daytime functioning, and what you've tried. Sleep aids — prescription and over-the-counter — and whether they've worked or stopped working are part of the history.

The evaluation also covers the conditions most commonly driving insomnia: anxiety, depression, ADHD, PTSD, and bipolar disorder. These often go unrecognized as the primary source of the sleep problem. A patient who has been managing insomnia with a Z-drug for three years may be treating a symptom while the underlying anxiety stays untreated.

Medical causes are factored in as well. Sleep apnea, restless legs, thyroid dysfunction, and medication side effects can all disrupt sleep. If a medical workup seems warranted, the provider will say so.

By the end of the appointment, you'll have a clearer picture of what's driving the insomnia and a treatment plan that addresses the cause — not just the sleep.

Common misconceptions about insomnia treatment

Melatonin is a sedative. It isn't. Melatonin signals to the brain that it's nighttime — it affects circadian timing, not sleep onset. For delayed sleep phase (going to bed very late, struggling to wake early), melatonin can help shift the schedule earlier. For the kind of insomnia where you lie awake for hours regardless of bedtime, it does little.

A better sleep aid will fix the problem. Sleep aids address the symptom, not the cause. Zolpidem helps you fall asleep; it doesn't treat the anxiety that's keeping you awake. When the medication wears off, the underlying condition remains. Long-term sleep medication without treating the root issue is managing a symptom indefinitely.

Sleep restriction sounds like it would make things worse. This is counterintuitive but central to CBT-I. Temporarily limiting time in bed consolidates sleep and breaks the frustration cycle of lying awake. Patients often resist it because it sounds punishing — it is uncomfortable briefly, before sleep quality improves. The discomfort is temporary. The results are more durable than medication alone.